About Archimedes Capital
Archimedes Capital invests in a range of venture capital and private equity deals, from seed to pre-IPO or later, focusing on those opportunities that utilize or can be accelerated to success with what we call global advantage. Global advantage is a set of resources and operating practices involving world-class but low-cost R&D, manufacturing, and operations outside of the US that dramatically improve operating economics, and an ability to sell into large and willing global markets that maximimze early customer traction and overall revenues. Global advantage combines US capital, US management and core technology expertise, and US liquidity with the strengths and markets the rest of the world has to offer to reduce capital requirements, reduce risk, and improve returns for Archimedes' portfolio. Archimedes' principals have been building and advising companies for nearly three decades using the global advantage approach. We have invested over $350 million since 1993 with a significant multiple cash on cash return and helped entrepreneurs create multiple billions of dollars of value. Among other critical marketplaces, we have decades of on-the-ground experience in China, advising banks, technology companies, central and provincial government officials, guiding technology and investment policy, and creating real companies that exemplify the global advantage model.